Horizon Therapeutics Public Ltd Co financial data

Industry
Pharmaceutical Preparations
Location
Connaught House, 1 St Floor, 1 Burlington Road, Dublin, Ireland
State of incorporation
Ireland
Fiscal year end
December 31
Former names
Horizon Pharma plc (to 5/2/2019), HORIZON PHARMA, INC. (to 9/19/2014)
Latest financial report
10-Q - Q2 2023 - Aug 8, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 404 % +19.3%
Quick Ratio 19.2 % -27.7%
Return On Equity 8.54 % -47.3%
Return On Assets 4.81 % -45.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 229M shares -0.6%
Common Stock, Shares, Outstanding 229M shares -0.61%
Entity Public Float 18.3B USD -12.4%
Common Stock, Value, Issued 23K USD 0%
Weighted Average Number of Shares Outstanding, Basic 229M shares -0.56%
Weighted Average Number of Shares Outstanding, Diluted 234M shares -0.95%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 3.64B USD -4.42%
Research and Development Expense 516M USD +45.6%
Operating Income (Loss) 513M USD -39.4%
Nonoperating Income (Expense) -69.5M USD +24.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 444M USD -41.3%
Income Tax Expense (Benefit) 5.86M USD +115%
Net Income (Loss) Attributable to Parent 438M USD -42.7%
Earnings Per Share, Basic 1.92 USD/shares -43.2%
Earnings Per Share, Diluted 1.86 USD/shares -43.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.46B USD +30.2%
Accounts Receivable, after Allowance for Credit Loss, Current 717M USD +6.55%
Inventory, Net 170M USD -16.4%
Assets, Current 3.92B USD +22.4%
Deferred Income Tax Assets, Net 444M USD -13.9%
Property, Plant and Equipment, Net 362M USD +19.9%
Operating Lease, Right-of-Use Asset 142M USD +49.7%
Intangible Assets, Net (Excluding Goodwill) 3.3B USD -9.95%
Goodwill 1.01B USD 0%
Other Assets, Noncurrent 263M USD +63.8%
Assets 9.3B USD +5.03%
Accounts Payable, Current 85.5M USD +361%
Employee-related Liabilities, Current 98.5M USD +20.8%
Accrued Liabilities, Current 497M USD +18.5%
Liabilities, Current 918M USD +16%
Deferred Income Tax Liabilities, Net 265M USD -27.7%
Operating Lease, Liability, Noncurrent 159M USD +46.4%
Other Liabilities, Noncurrent 264M USD +32.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax 21.6M USD
Retained Earnings (Accumulated Deficit) 772M USD +32.2%
Stockholders' Equity Attributable to Parent 5.31B USD +7.39%
Liabilities and Equity 9.3B USD +5.03%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 86.3M USD -60%
Net Cash Provided by (Used in) Financing Activities -88.1M USD +19.9%
Net Cash Provided by (Used in) Investing Activities -41.8M USD -2.52%
Common Stock, Shares Authorized 600M shares 0%
Common Stock, Shares, Issued 229M shares -0.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -41.2M USD -165%
Interest Paid, Excluding Capitalized Interest, Operating Activities 43.6M USD +55.1%
Deferred Tax Assets, Valuation Allowance 18.7M USD -50.3%
Deferred Tax Assets, Gross 226M USD -13.7%
Operating Lease, Liability 168M USD +48.1%
Depreciation 24.8M USD +14.5%
Payments to Acquire Property, Plant, and Equipment 24.1M USD +69.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 475M USD -36.8%
Lessee, Operating Lease, Liability, to be Paid 298M USD +99.2%
Property, Plant and Equipment, Gross 433M USD +23.8%
Operating Lease, Liability, Current 9.2M USD +84%
Lessee, Operating Lease, Liability, to be Paid, Year Two 14.6M USD +21.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 13.1M USD +108%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure +22.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 129M USD +262%
Lessee, Operating Lease, Liability, to be Paid, Year Three 20M USD +54.7%
Unrecognized Tax Benefits 30.4M USD +6.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 21.5M USD +75.9%
Amortization of Intangible Assets 364M USD +0.58%
Depreciation, Depletion and Amortization 94.9M USD -0.27%
Deferred Tax Assets, Net of Valuation Allowance 208M USD -7.56%
Share-based Payment Arrangement, Expense 193M USD -5.99%